5

DPP-4-Inhibitoren in der Klinik. Therapie ohne Hypoglykämie-Gefahr

Year:
2010
Language:
german
File:
PDF, 446 KB
german, 2010
8

Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus

Year:
2010
Language:
english
File:
PDF, 324 KB
english, 2010
9

Novel Oral Anti-Obesity Agents: New Perspectives with Lorcaserin?

Year:
2013
Language:
english
File:
PDF, 167 KB
english, 2013
12

A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes

Year:
2017
Language:
english
File:
PDF, 902 KB
english, 2017
17

Inkretine: Gibt es kardiovaskuläre Effekte?

Year:
2010
File:
PDF, 626 KB
2010
19

The evolving place of incretin-based therapies in type 2 diabetes

Year:
2010
Language:
english
File:
PDF, 281 KB
english, 2010